Evidence map›Paper›PMID 20347861›Full record

ReviewFrontiers in neuroendocrinology2010

The pros and cons of phytoestrogens.

Heather B Patisaul, Wendy Jefferson

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 221 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
221citing papers in PubMed, 4 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

221 citing papers in PubMed, 4 syntheses or guidelines pooled it, 732 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Tualang Honey: A Decade of Neurological Research.Molecules (Basel, Switzerland) · 2021
    Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Effect ofLife (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Formononetin: pharmacological properties and therapeutic potential.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  19. Article
  20. Review

161 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Heather B PatisaulDepartment of Biology, NC State University, Raleigh, NC 27695, USA. heather_patisaul@ncsu.edu
Wendy Jefferson
National Institute of Environmental Health Sciences · USNorth Central State College · US

Funding

Endocrine Disruption of the Hypothalamic Signaling That Regulates PubertyR01ES016001 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI PATISAUL, HEATHER B · 2007 to 2011
$2.0M
Intramural NIH HHS Z99 ES999999NIEHS NIH HHS R01 ES016001
6 · The paper itself

Abstract

Phytoestrogens are plant derived compounds found in a wide variety of foods, most notably soy. A litany of health benefits including a lowered risk of osteoporosis, heart disease, breast cancer, and menopausal symptoms, are frequently attributed to phytoestrogens but many are also considered endocrine disruptors, indicating that they have the potential to cause adverse health effects as well. Consequently, the question of whether or not phytoestrogens are beneficial or harmful to human health remains unresolved. The answer is likely complex and may depend on age, health status, and even the presence or absence of specific gut microflora. Clarity on this issue is needed because global consumption is rapidly increasing. Phytoestrogens are present in numerous dietary supplements and widely marketed as a natural alternative to estrogen replacement therapy. Soy infant formula now constitutes up to a third of the US market, and soy protein is now added to many processed foods. As weak estrogen agonists/antagonists with molecular and cellular properties similar to synthetic endocrine disruptors such as Bisphenol A (BPA), the phytoestrogens provide a useful model to comprehensively investigate the biological impact of endocrine disruptors in general. This review weighs the evidence for and against the purported health benefits and adverse effects of phytoestrogens.

Indexed as

AnimalsBrainBreast NeoplasmsDiethylstilbestrolEndocrine DisruptorsFemaleGenitaliaHeart DiseasesHumansMaleMenopauseMenstrual CycleMiceOsteoporosisPhytoestrogensPubertyDiethylstilbestrolEndocrine DisruptorsPhytoestrogensSoybean Proteins

Identifiers

PMID20347861
PMCPMC3074428
OpenAlexW2058683100

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.